跳至主要内容
临床试验/CTRI/2024/07/069979
CTRI/2024/07/069979尚未招募Unknown

To study the utility of serum lipids and CEA levels as novel markers in comparison to various histopathological parameters and Tumor Node Metastasis(TNM) staging in colorectal carcinoma. - NI

Datta Meghe Institute of Higher Education and Research0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
Unknown
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

入选标准

  • Patients with a diagnosis confirmed through histopathological examination.
  • Patients with colorectal carcinoma that has originated de novo (without prior related history).
  • Primary cases of colorectal carcinoma with no history of previous treatment.
  • Patients who are not taking lipid-lowering medications.

排除标准

  • Patients who are taking lipid-lowering medications.
  • Patients who are receiving neoadjuvant chemotherapy for colorectal carcinoma.
  • Patients who have previously undergone surgical procedures for colorectal cancer before being enrolled in the study.

研究者

发起方
Datta Meghe Institute of Higher Education and Research

相似试验